431 related articles for article (PubMed ID: 16003765)
1. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
Jann S; Beretta S; Bramerio MA
Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of electrodiagnostic criteria for CIDP using ROC curves: comparison to patients with diabetic and MGUS associated neuropathies.
Wilson J; Chawla J; Fisher M
J Neurol Sci; 2005 Apr; 231(1-2):19-28. PubMed ID: 15792816
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory demyelinating polyradiculoneuropathy in diabetic patients.
Haq RU; Pendlebury WW; Fries TJ; Tandan R
Muscle Nerve; 2003 Apr; 27(4):465-70. PubMed ID: 12661048
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
5. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of intravenous immunoglobulin in CIDP.
Vucic S; Black K; Baldassari LE; Tick Chong PS; Dawson KT; Cros D
Clin Neurophysiol; 2007 Sep; 118(9):1980-4. PubMed ID: 17604689
[TBL] [Abstract][Full Text] [Related]
7. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
8. Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.
Boërio D; Créange A; Hogrel JY; Guéguen A; Bertrand D; Lefaucheur JP
J Neurol Sci; 2010 May; 292(1-2):63-71. PubMed ID: 20219211
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyneuropathy in a diabetic patient: deterioration after intravenous immunoglobulins treatment and favorable response to steroid treatment.
Pedersen K; Pandolfo M; Mavroudakis N
Acta Neurol Belg; 2007 Mar; 107(1):14-7. PubMed ID: 17569228
[TBL] [Abstract][Full Text] [Related]
10. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Lopate G; Pestronk A; Al-Lozi M
Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
[TBL] [Abstract][Full Text] [Related]
11. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
Vina ER; Fang AJ; Wallace DJ; Weisman MH
Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
[TBL] [Abstract][Full Text] [Related]
12. [Epidemiological and clinical aspects of CIDP].
Viala K
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S31-5. PubMed ID: 18087227
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up.
Jann S; Bramerio MA; Facchetti D; Sterzi R
J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):70-3. PubMed ID: 18768571
[TBL] [Abstract][Full Text] [Related]
14. Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP.
Iijima M; Yamamoto M; Hirayama M; Tanaka F; Katsuno M; Mori K; Koike H; Hattori N; Arimura K; Nakagawa M; Yoshikawa H; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakazato M; Nakashima K; Kira J; Kaji R; Oka N; Sobue G
Neurology; 2005 Apr; 64(8):1471-5. PubMed ID: 15851750
[TBL] [Abstract][Full Text] [Related]
15. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
Uzenot D; Azulay JP; Pouget J
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
[TBL] [Abstract][Full Text] [Related]
16. Chronic inflammatory demyelinating polyneuropathy and other immune-mediated demyelinating neuropathies.
Lewis RA
Semin Neurol; 2005 Jun; 25(2):217-28. PubMed ID: 15937737
[TBL] [Abstract][Full Text] [Related]
17. [Intermittent intravenous immunoglobulin infusion prevented relapses in patients with remission-exacerbation type chronic inflammatory demyelinating polyradiculoneuropathy].
Kanda F; Sekiguchi K; Oishi K; Hamaguchi H; Mitsui S; Kobessho H; Higuchi M; Shirafuji T; Ishihara H
Rinsho Shinkeigaku; 2006 Mar; 46(3):236-8. PubMed ID: 16642939
[TBL] [Abstract][Full Text] [Related]
18. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
[TBL] [Abstract][Full Text] [Related]
19. Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2009 Apr; 39(4):439-47. PubMed ID: 19229876
[TBL] [Abstract][Full Text] [Related]
20. [A case of CIDP with diabetes mellitus who had good response to intravenous immune globulin].
Nakano M; Takase Y; Tatsumi C; Miura A; Matsuyama T; Kadekawa J; Yoshikawa H
Rinsho Shinkeigaku; 2002 Jan; 42(1):32-4. PubMed ID: 12355849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
